Related references
Note: Only part of the references are listed.Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
Wei-Zhan Zhuang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient
Javier Lopez-Beas et al.
MEDICINAL RESEARCH REVIEWS (2020)
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Abdelkrim Hmadcha et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Abraham S. Kanate et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Shattering barriers toward clinically meaningful MSC therapies
Oren Levy et al.
SCIENCE ADVANCES (2020)
Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential
Na Song et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Stem cells: past, present, and future
Wojciech Zakrzewski et al.
STEM CELL RESEARCH & THERAPY (2019)
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
Carolina Iglesias-Lopez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Mesenchymal stem cell perspective: cell biology to clinical progress
Mark F. Pittenger et al.
NPJ REGENERATIVE MEDICINE (2019)
Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe
Renske M. T. ten Ham et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Understanding FDA Regulatory Requirements for Investigational New Drug Applications for Sponsor-Investigators
M. E. Blair Holbein
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Human mesenchymal stem cells - current trends and future prospective
Imran Ullah et al.
BIOSCIENCE REPORTS (2015)
Regulatory Landscape of Regenerative Medicine in Japan
Kentaro Azuma
CURRENT STEM CELL REPORTS (2015)
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Michael Mendicino et al.
CELL STEM CELL (2014)
Hematopoietic Stem Cell Transplantation-50 Years of Evolution and Future Perspectives
Israel Henig et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2014)
Mesenchymal stem cells: a new trend for cell therapy
Xin Wei et al.
ACTA PHARMACOLOGICA SINICA (2013)
Overcoming Challenges to Initiating Cell Therapy Clinical Trials in Rapidly Developing Countries: India as a Model
Sowmya Viswanathan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
Jains Ancans
FRONTIERS IN IMMUNOLOGY (2012)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Biology of stem cells: an overview
Pedro C. Chagastelles et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2011)
Mesenchymal Stem Cells as Therapeutics
Biju Parekkadan et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 12 (2010)
Challenges with advanced therapy medicinal products and how to meet them
Christian K. Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Mesenchymal stem cells in hematopoietic stem cell transplantation
Minoo Battiwalla et al.
CYTOTHERAPY (2009)
Regulation of tissue-engineered products in the European Union:: where are we heading?
Laure Brevignon-Dodin et al.
REGENERATIVE MEDICINE (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Current issues in the regulation of human tissue-engineering products in the European Union
M Heinonen et al.
TISSUE ENGINEERING (2005)
Animal experimentation and ethics in India: The CPCSEA makes a difference
S Pereira et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2004)
Share Paper
